Total Payments
$14,067
2024 Payments
$1,430
Companies
56
Transactions
657
Medicare Patients
15,371
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$13,325 (94.7%)
Education$742.26 (5.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,325 | 637 | 94.7% |
| Education | $742.26 | 11 | 5.3% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$14,067
648 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $2,186 | 112 | $0 (2023) |
| Janssen Biotech, Inc. | $1,478 | 72 | $0 (2024) |
| PFIZER INC. | $1,262 | 76 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,058 | 32 | $0 (2024) |
| COLOPLAST CORP | $634.33 | 28 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $585.87 | 30 | $0 (2024) |
| UROGEN PHARMA, INC. | $566.35 | 12 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $487.91 | 26 | $0 (2022) |
| Merck Sharp & Dohme LLC | $473.54 | 24 | $0 (2024) |
| NeoTract Inc. | $467.86 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,430 | 63 | Janssen Biotech, Inc. ($274.75) |
| 2023 | $1,663 | 64 | PROCEPT BioRobotics Corporation ($265.47) |
| 2022 | $2,256 | 93 | Janssen Biotech, Inc. ($416.84) |
| 2021 | $2,206 | 101 | Astellas Pharma US Inc ($378.42) |
| 2020 | $1,308 | 67 | Astellas Pharma US Inc ($267.86) |
| 2019 | $2,031 | 100 | Astellas Pharma US Inc ($379.00) |
| 2018 | $1,887 | 95 | PFIZER INC. ($399.28) |
| 2017 | $1,287 | 74 | Astellas Pharma US Inc ($340.99) |
All Payment Transactions
657 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $29.74 | General |
| 12/02/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Prostate cancer | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/07/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.84 | General |
| Category: Prostate cancer | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/17/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Oncology | ||||||
| 08/29/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: UROLOGY | ||||||
| 08/06/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/31/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 3,628 | 25,296 | $882,234 | $261,300 |
| 2022 | 36 | 3,920 | 38,997 | $1.0M | $279,805 |
| 2021 | 39 | 4,136 | 47,423 | $1.2M | $284,303 |
| 2020 | 38 | 3,687 | 43,814 | $1.1M | $237,441 |
Total Patients
15,371
Total Services
155,530
Medicare Billing
$1.1M
Procedure Codes
163
All Medicare Procedures & Services
163 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 168 | 1,352 | $87,880 | $58,807 | 66.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 510 | 607 | $115,757 | $35,569 | 30.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 27 | 207 | $155,628 | $27,156 | 17.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,440 | $64,800 | $26,589 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 292 | $80,864 | $23,207 | 28.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 83 | 104 | $56,304 | $16,388 | 29.1% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 23 | 24 | $43,644 | $10,410 | 23.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 337 | 437 | $34,960 | $7,875 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 77 | 77 | $20,896 | $5,358 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $18,570 | $4,942 | 26.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 79 | 135 | $10,800 | $4,584 | 42.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 380 | 508 | $5,080 | $4,267 | 84.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 22 | 22 | $15,884 | $4,041 | 25.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 98 | 106 | $12,720 | $3,897 | 30.6% |
| 51705 | Simple change of bladder tube | Office | 2023 | 34 | 41 | $10,159 | $2,578 | 25.4% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 13 | 1,000 | $7,900 | $2,260 | 28.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 666 | 948 | $11,436 | $2,082 | 18.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 24 | 27 | $9,605 | $2,061 | 21.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 18 | $21,863 | $2,053 | 9.4% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 22 | 31 | $9,532 | $1,878 | 19.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 56 | 71 | $7,455 | $1,796 | 24.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 224 | 276 | $19,014 | $1,774 | 9.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 66 | 89 | $3,418 | $1,242 | 36.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 25 | 31 | $6,029 | $1,224 | 20.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $8,088 | $1,200 | 14.8% |
About Dr. Wesley Brookover, MD
Dr. Wesley Brookover, MD is a Urology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659457455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wesley Brookover, MD has received a total of $14,067 in payments from pharmaceutical and medical device companies, with $1,430 received in 2024. These payments were reported across 657 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,325).
As a Medicare-enrolled provider, Brookover has provided services to 15,371 Medicare beneficiaries, totaling 155,530 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 163 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Tulsa, OK
- Active Since 10/27/2006
- Last Updated 07/05/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1659457455
Products in Payments
- XTANDI (Drug) $1,518
- PROVENGE (Drug) $1,110
- ERLEADA (Drug) $956.36
- MYRBETRIQ (Drug) $602.81
- ELIGARD (Drug) $539.41
- SpeediCath (Device) $484.59
- KEYTRUDA (Biological) $473.54
- Nubeqa (Drug) $448.80
- Erleada (Drug) $398.02
- UroLift (Device) $393.70
- JELMYTO (Drug) $340.12
- Axumin (Drug) $311.76
- Myrbetriq (Drug) $305.33
- GEMTESA (Drug) $278.66
- AQUABEAM ROBOTIC SYSTEM (Device) $265.47
- XIAFLEX (Biological) $245.75
- Rubraca (Drug) $212.06
- ORGOVYX (Drug) $211.05
- Trelstar (Drug) $195.64
- TOVIAZ (Drug) $195.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Tulsa
Dr. Melanie Ketchandji, M.d, M.D
Urology — Payments: $90,749
Urology $90,749
Scott Litwiller, Md, MD
Urology — Payments: $41,382
Urology $41,382
Dr. Sean Doyle, M.d, M.D
Urology — Payments: $31,400
Urology $31,400
Charles Pritchard, Md, MD
Urology — Payments: $24,283
Urology $24,283
Marc Milsten, Md, MD
Urology — Payments: $23,702
Urology $23,702
Dr. Curtis Powell, M.d, M.D
Urology — Payments: $17,755
Urology $17,755